Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2012 1
2013 1
2014 4
2015 4
2016 5
2017 2
2018 2
2019 2
2020 9
2021 18
2022 17
2023 13
2024 7
2025 5
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study.
Gutiérrez-Gutiérrez B, Del Toro MD, Borobia AM, Carcas A, Jarrín I, Yllescas M, Ryan P, Pachón J, Carratalà J, Berenguer J, Arribas JR, Rodríguez-Baño J; REIPI-SEIMC COVID-19 group and COVID@HULP groups. Gutiérrez-Gutiérrez B, et al. Lancet Infect Dis. 2021 Jun;21(6):783-792. doi: 10.1016/S1473-3099(21)00019-0. Epub 2021 Feb 23. Lancet Infect Dis. 2021. PMID: 33636145 Free PMC article.
Measles inclusion body encephalitis.
Aldecoa I, Archilla I, Herrero L, Garcia F, Torres B, Gaig C, Fernández S, Marcos MÁ, Gelpi E. Aldecoa I, et al. Among authors: torres b. Clin Neuropathol. 2020 Jul/Aug;39(4):148-151. doi: 10.5414/NP301283. Clin Neuropathol. 2020. PMID: 32507126 Free PMC article.
Overview of SARS-CoV-2 infection in adults living with HIV.
Ambrosioni J, Blanco JL, Reyes-Urueña JM, Davies MA, Sued O, Marcos MA, Martínez E, Bertagnolio S, Alcamí J, Miro JM; COVID-19 in HIV Investigators. Ambrosioni J, et al. Lancet HIV. 2021 May;8(5):e294-e305. doi: 10.1016/S2352-3018(21)00070-9. Lancet HIV. 2021. PMID: 33915101 Free PMC article. Review.
Personalized Therapy Approach for Hospitalized Patients with Coronavirus Disease 2019.
Garcia-Vidal C, Moreno-García E, Hernández-Meneses M, Puerta-Alcalde P, Chumbita M, Garcia-Pouton N, Linares L, Rico V, Cardozo C, Martínez JA, García F, Mensa J, Castro P, Nicolás JM, Muñoz J, Vidal D, Soriano A; COVID19-Researchers. Garcia-Vidal C, et al. Clin Infect Dis. 2022 Jan 7;74(1):127-132. doi: 10.1093/cid/ciaa964. Clin Infect Dis. 2022. PMID: 32649747 Free PMC article.
48 Week body composition changes in persons with HIV switching to dolutegravir plus lamivudine: a planned subanalysis of the DOLAM randomized clinical trial.
de Lazzari E, Di Gregorio S, Rojas J, Curran A, Domingo P, Negredo E, Tiraboschi J, Gonzalez-Cordon A, Torres B, Sempere A, Inciarte A, Gatell JM, Blanco JL, Martinez E; DOLAM study group. de Lazzari E, et al. Among authors: torres b. J Antimicrob Chemother. 2025 Aug 1;80(8):2226-2233. doi: 10.1093/jac/dkaf192. J Antimicrob Chemother. 2025. PMID: 40556520 Clinical Trial.
Long-Term Health Outcomes of People with HIV Engaged in Chemsex: A Prospective Cohort Study on Drug Use, Sexual Behaviour, Sexually-Transmitted Infections and Vulnerability.
De La Mora L, Laguno M, Torres B, Chivite I, Foncillas A, Inciarte A, Calvo J, González-Cordón A, Ambrosioni J, Berrocal L, De Lazzari E, Martínez E, Blanco JL, Mora R, Solbes E, Rodriguez A, Callau P, Miquel L, Blanch J, Short D, Mallolas J, Martínez-Rebollar M. De La Mora L, et al. Among authors: torres b. Infect Dis Ther. 2025 Sep;14(9):2113-2130. doi: 10.1007/s40121-025-01201-7. Epub 2025 Aug 5. Infect Dis Ther. 2025. PMID: 40762951 Free PMC article.
Integrase inhibitors in children and adolescents: clinical use and resistance.
Torres-Fernandez D, Jiménez de Ory S, Fortuny C, Sainz T, Falcón D, Bernal E, Jiménez MC, Vilasaró MN, Epalza C, Navarro M, Ramos JT, Holguín Á, Prieto L; CoRIS and CoRISpe Spanish National Cohorts, CoRISpe and CoRISpe-FARO Cohort Working Group. Torres-Fernandez D, et al. J Antimicrob Chemother. 2022 Sep 30;77(10):2784-2792. doi: 10.1093/jac/dkac259. J Antimicrob Chemother. 2022. PMID: 35971971
[Diagnosis and treatment of intracerebral hemorrhage].
Ruiz JL, Colorado H, Loy Mdel C, Millán R, Talamás O, Torres B, Vargas R, Cantú C, Araúz A, Barinagarrementeria F. Ruiz JL, et al. Among authors: torres b. Rev Invest Clin. 2002 May-Jun;54(3):275-80. Rev Invest Clin. 2002. PMID: 12183899 Review. Spanish. No abstract available.
Efficacy and safety of raltegravir plus lamivudine maintenance therapy.
Borjabad B, Inciarte A, Chivite I, Gonzalez-Cordon A, Mosquera M, Hurtado C, Rovira C, Gonzalez T, Sempere A, Torres B, Calvo J, De La Mora L, Martinez-Rebollar M, Laguno M, Foncillas A, Ambrosioni J, Blanch J, Rodriguez A, Solbes E, Llobet R, Berrocal L, Mallolas J, Miro JM, Alcami J, Blanco JL, Sanchez-Palomino S, De Lazzari E, Martinez E. Borjabad B, et al. Among authors: torres b. J Antimicrob Chemother. 2024 Feb 1;79(2):255-261. doi: 10.1093/jac/dkad364. J Antimicrob Chemother. 2024. PMID: 38039097 Clinical Trial.
Tolerability of bictegravir/tenofovir alafenamide/emtricitabine versus dolutegravir/lamivudine as maintenance therapy in a real-life setting.
Rocabert A, Borjabad B, Berrocal L, Blanch J, Inciarte A, Chivite I, Gonzalez-Cordon A, Torres B, Ambrosioni J, Martinez-Rebollar M, Laguno M, De La Mora L, Foncillas A, Sempere A, Rodriguez A, Solbes E, Llobet R, Miro JM, Mallolas J, Blanco JL, De Lazzari E, Martinez E. Rocabert A, et al. Among authors: torres b. J Antimicrob Chemother. 2023 Dec 1;78(12):2961-2967. doi: 10.1093/jac/dkad338. J Antimicrob Chemother. 2023. PMID: 37875023
86 results